Extracellular vesicle contents as non-invasive biomarkers in ovarian malignancies

Ovarian cancer most commonly presents at an advanced stage where survival is approximately 30% compared with >80% if diagnosed and treated before disease spreads. Diagnostic capabilities have progressed from surgical staging via laparotomy to image-guided biopsies and immunohistochemistry stainin...

Descripción completa

Detalles Bibliográficos
Autores principales: McAlarnen, Lindsey A., Gupta, Prachi, Singh, Reena, Pradeep, Sunila, Chaluvally-Raghavan, Pradeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420349/
https://www.ncbi.nlm.nih.gov/pubmed/36090475
http://dx.doi.org/10.1016/j.omto.2022.08.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420349/
https://www.ncbi.nlm.nih.gov/pubmed/36090475
http://dx.doi.org/10.1016/j.omto.2022.08.005

Ejemplares similares